Targeted radiation for breast cancer that has spread and is growing a little
Part of Cancer, Skin clinical trials.
This trial tests whether giving focused, high-dose radiation to spots where the cancer is growing can help control the disease while you stay on your current hormone therapy and/or CDK4/6 inhibitor. It is for people with ER+/HER2- breast cancer that has spread to a few places and is slowly starting to progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your breast cancer is ER-positive and HER2-negative and has spread to other parts of your body.
- You have 1 to 3 spots outside the brain where the cancer is growing, and these can be treated with focused radiation.
- You have been on your first or second hormone therapy (with or without a CDK4/6 inhibitor) for at least 6 months before the growth started.
- You feel well enough to do daily activities (ECOG performance status 0 to 2).
- You are not pregnant, and you can sign a consent form.
- You have not already had radiation to the same growing spots while on your current treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving precise radiation to a limited number of growing spots can help control melanoma that has spread but is otherwise stable on immunotherapy or targeted therapy. You may join if you have up to 10 growing spots outside the brain that can be safely treated with focused radiation.
This trial compares two types of radiation for people whose cancer has spread to a few new spots while on or after treatment. It tests whether a precise, high-dose radiation approach (stereotactic) works better than the usual palliative radiation for controlling these growing spots.
This study tests whether adding targeted radiation to your current lung cancer pill can help control areas where the cancer has started to grow again. It may help you delay needing to switch treatments.
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
This trial tests whether targeted radiation (SBRT) to a few sites of cancer spread can help men whose prostate cancer has stopped responding to hormone therapy but has not spread to many places. You may benefit if you have a limited number of growing spots outside the brain or spine.
This trial tests whether focused radiation (SBRT) can treat a few new spots of breast cancer that appear while you are on your first treatment. The goal is to keep your current treatment working longer without needing to switch medications.
Hear when a new OligoProgressive Metastatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.